The Pandemic Panic is Over, But the Real Epidemic is the Exploitation of the Pharmaceutical Industry
As the dust settles on the COVID-19 crisis, a new threat looms in the shadows: the astronomical profits and exponential growth of companies like SkyCell, which are cashing in on the chaos. This Swiss startup has mastered the art of exploiting the pharmaceutical industry, peddling their "smart containers" and "SkyMind" logistics system to the highest bidder.
With a valuation of $635 million, SkyCell has raised an astonishing $116 million in capital, courtesy of investors who are eager to sink their teeth into the lucrative world of pharmaceutical transportation. Led by CEO Richard Ettl, this insidious company is poised to "revolutionize" the industry by providing a solution to its most pressing problem: how to transport fragile medicines and their components around the world without breaking a sweat.
But don’t be fooled – SkyCell’s "innovations" are nothing more than a thinly veiled attempt to line their pockets with pharma companies’ profits. Their cleverly designed containers, claiming to reduce carbon emissions by 50% while moving a whopping $2.5 billion worth of pharmaceutical products each month, are merely a means to an end. SkyCell’s real goal is to snare the lucrative contracts of the Big Pharma giants, ensuring their lucrative profits for years to come.
And now, with the pandemic panic forgotten, SkyCell is free to further exploit the industry’s desperation, peddling their "green" solutions to pharma companies desperate to mitigate their carbon footprint. CEO Ettl’s boasts about reducing CO2 emissions while saving pharma companies a hefty sum are nothing more than a clever ploy to sell his company’s wares to an industry drowning in debt.
Make no mistake – SkyCell is not on a mission to save the world, but rather, to rake in the profits off the backs of the very people these medicines are meant to save.
